Annals of Surgical Oncology

, Volume 20, Issue 6, pp 1949–1954 | Cite as

Predictive Factors of Lymph Node Status in Small Peripheral Non-small Cell Lung Cancers: Tumor Histology is More Reliable

  • Yang Zhang
  • Yihua Sun
  • Lei Shen
  • Yuan Li
  • Jiaqing Xiang
  • Yawei Zhang
  • Hong Hu
  • Haiquan Chen
Thoracic Oncology

Abstract

Background

During the past two decades, many studies have sought to find reliable predictors of N0 status in small-sized lung cancers. However, the way of tumor size measurement was usually not clearly stated, and controversy remains as to whether systematic lymph node dissection should be performed in patients with subcentimeter tumors.

Methods

We reviewed correlations between lymph node involvement and clinicopathological variables in 243 small peripheral non-small cell lung cancers with their size measured in fresh specimens before formalin fixation. Histologic subtypes of adenocarcinomas were classified in line with the new International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) lung adenocarcinoma classification.

Results

Incidence of N1 and N2 nodal involvement was 5.3 and 6.6 %, respectively. N2 disease was present in a proportion of subcentimeter tumors (2/53, 3.8 %). No lymph node metastasis was revealed in squamous cell carcinomas, adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma. Collectively, the five cell types accounted for 34.6 % of all the small peripheral cases.

Conclusions

Precise measurement of tumor size in fresh tissues revealed that tumor size was not a reliable predictor of N0 status. However, through histologic classification, systematic lymph node dissection might be avoided in more than one third of small peripheral NSCLC.

References

  1. 1.
    Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2(7):593–602.PubMedCrossRefGoogle Scholar
  2. 2.
    Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–22; discussion 622–3.Google Scholar
  3. 3.
    Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81(3):1013–9; discussion 1019–20.Google Scholar
  4. 4.
    Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136(1):260–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998;21(3):185–91.PubMedCrossRefGoogle Scholar
  6. 6.
    Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20(5):1007–11.PubMedCrossRefGoogle Scholar
  7. 7.
    Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter. Ann Thorac Surg. 2004;78(3):1011–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Shi CL, Zhang XY, Han BH, He WZ, Shen J, Chu TQ. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment. Med Oncol. 2011;28(4):1441–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Fukui T, Katayama T, Ito S, Abe T, Hatooka S, Mitsudomi T. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer. 2009;66(3):309–13.PubMedCrossRefGoogle Scholar
  10. 10.
    Lampen-Sachar K, Zhao B, Zheng J, et al. Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas. Lung Cancer. 2012;75(3):332–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.PubMedCrossRefGoogle Scholar
  12. 12.
    Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6(9):1496–504.PubMedCrossRefGoogle Scholar
  13. 13.
    Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409–19.PubMedCrossRefGoogle Scholar
  14. 14.
    Veronesi G, Maisonneuve P, Pelosi G, et al. Screening-detected lung cancers: is systematic nodal dissection always essential? J Thorac Oncol. 2011;6(3):525–30.PubMedCrossRefGoogle Scholar
  15. 15.
    Casiraghi M, Travaini LL, Maisonneuve P, et al. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg. 2011;39(4):e38–43.PubMedCrossRefGoogle Scholar
  16. 16.
    Miller DL, Rowland CM, Deschamps C, Allen MS, Trastek VF, Pairolero PC. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg. 2002;73(5):1545–50; discussion 1550–1.Google Scholar
  17. 17.
    Zhou Q, Suzuki K, Anami Y, Oh S, Takamochi K. Clinicopathologic features in resected subcentimeter lung cancer—status of lymph node metastases. Interact Cardiovasc Thorac Surg. 2010;10(1):53–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Sakurai H, Asamura H, Watanabe S, Suzuki K, Tsuchiya R. Clinicopathologic features of peripheral squamous cell carcinoma of the lung. Ann Thorac Surg. 2004;78(1):222–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Xu L, Tavora F, Battafarano R, Burke A. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am J Surg Pathol. 2012;36(2):273–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Yeh YC, Nitadori J, Kadota K, Yoshizawa A, Rusch VW, Adusumilli PS, Travis WD. Accuracy of frozen sections (FS) in predicting predominant histologic subtype and presence/absence of micropapillary and solid patterns in lung adenocarcinoma (ADC) ≤ 3 cm. Mod Pathol. 2012;25(Suppl 2):493A.Google Scholar
  21. 21.
    Birim O, Kappetein AP, Stijnen T, Bogers AJ. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg. 2005;79(1):375–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Kozower BD, Meyers BF, Reed CE, Jones DR, Decker PA, Putnam JB Jr. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer? Ann Thorac Surg. 2008;85(4):1166–9; discussion 1169–70.Google Scholar

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • Yang Zhang
    • 1
    • 2
  • Yihua Sun
    • 1
    • 2
  • Lei Shen
    • 2
    • 3
  • Yuan Li
    • 2
    • 3
  • Jiaqing Xiang
    • 1
    • 2
  • Yawei Zhang
    • 1
    • 2
  • Hong Hu
    • 1
    • 2
  • Haiquan Chen
    • 1
    • 2
  1. 1.Department of Thoracic SurgeryFudan University Shanghai Cancer CenterShanghaiChina
  2. 2.Department of OncologyShanghai Medical College, Fudan UniversityShanghaiChina
  3. 3.Department of PathologyFudan University Shanghai Cancer CenterShanghaiChina

Personalised recommendations